Company record
K. Boeun Pharmaceutical Co., Ltd.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about K. Boeun Pharmaceutical Co., Ltd..
Warning letters
-
DrugsK. Boeun Pharmaceutical Co., Ltd.
K. Boeun Pharmaceutical's OTC drugs were cited for CGMP violations, including missing identity tests for DEG/EG-risk components and inadequate quality unit.
High risk